Home › Agent Hub › Agent Tools › Part D coverage by drug › Ingrezza
Agent Tools
Ingrezza is a brand of valbenazine. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 1,922 of 5,492 Medicare Part D and Medicare Advantage drug plans (35%) list Ingrezza on their formulary, across 109 of 286 formularies. The most common placement is tier 5 (1,828 plans, 95.1% of those covering it). 1,826 of the covering plans require prior authorization (95%), 0 step therapy and 1,778 a quantity limit.
23 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $0, 23 of them $0; 1,899 charge coinsurance instead — median 26% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 2,733 of 5,496 plans covered it (49.7%); 2027: 1,922 of 5,492 (35%).
Of 4,367 plans offered in both years, 89 added it to the formulary and 554 dropped it.
Among plans covering it both years, 15 moved it to a higher tier and 6 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 49 |
| Tier 2 | 1 |
| Tier 4 | 44 |
| Tier 5 | 1,828 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 107 of 323 | 33.1% | 100% |
| Medicare Advantage with drugs (MA-PD) | 987 of 3,200 | 30.8% | 93.2% |
| Special needs plans (SNP) | 828 of 1,969 | 42.1% | 96.5% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 0 of 846 | No tier listed | 0 |
| UnitedHealthcare | 796 of 830 | Tier 5 | 796 |
| Devoted Health | 0 of 728 | No tier listed | 0 |
| Aetna Medicare | 0 of 631 | No tier listed | 0 |
| Wellcare | 268 of 268 | Tier 5 | 268 |
| HealthSpring | 0 of 226 | No tier listed | 0 |
| Kaiser Permanente | 112 of 112 | Tier 5 | 16 |
| SCAN Health Plan | 83 of 83 | Tier 5 | 83 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 0 of 77 | No tier listed | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 5 | 74 |
| Wellpoint | 58 of 63 | Tier 5 | 58 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 0 of 37 | No tier listed | 0 |
| Zing Health | 0 of 36 | No tier listed | 0 |
| Capital Blue Cross | 0 of 35 | No tier listed | 0 |
| Prominence Health Plan | 29 of 29 | Tier 5 | 29 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 22 of 26 | Tier 5 | 22 |
| Blue Cross Blue Shield of Michigan | 0 of 26 | No tier listed | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 17 of 114 | 14.9% |
| Alaska | 3 of 9 | 33.3% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 63 of 147 | 42.9% |
| Arkansas | 24 of 85 | 28.2% |
| California | 242 of 397 | 61% |
| Colorado | 39 of 106 | 36.8% |
| Connecticut | 20 of 54 | 37% |
| Delaware | 17 of 43 | 39.5% |
| District of Columbia | 8 of 12 | 66.7% |
| Florida | 170 of 545 | 31.2% |
| Georgia | 49 of 149 | 32.9% |
| Guam | 1 of 1 | 100% |
| Hawaii | 16 of 50 | 32% |
| Idaho | 17 of 45 | 37.8% |
| Illinois | 39 of 132 | 29.5% |
| Indiana | 60 of 138 | 43.5% |
| Iowa | 27 of 64 | 42.2% |
| Kansas | 21 of 84 | 25% |
| Kentucky | 47 of 121 | 38.8% |
| Louisiana | 49 of 125 | 39.2% |
| Maine | 22 of 52 | 42.3% |
| Maryland | 17 of 49 | 34.7% |
| Massachusetts | 24 of 89 | 27% |
| Michigan | 27 of 182 | 14.8% |
| Minnesota | 20 of 63 | 31.7% |
| Mississippi | 37 of 104 | 35.6% |
| Missouri | 54 of 170 | 31.8% |
| Montana | 5 of 27 | 18.5% |
| Nebraska | 17 of 51 | 33.3% |
| Nevada | 54 of 100 | 54% |
| New Hampshire | 8 of 25 | 32% |
| New Jersey | 28 of 73 | 38.4% |
| New Mexico | 31 of 68 | 45.6% |
| New York | 57 of 215 | 26.5% |
| North Carolina | 61 of 176 | 34.7% |
| North Dakota | 11 of 26 | 42.3% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 75 of 171 | 43.9% |
| Oklahoma | 27 of 81 | 33.3% |
| Oregon | 37 of 92 | 40.2% |
| Pennsylvania | 58 of 323 | 18% |
| Puerto Rico | 1 of 64 | 1.6% |
| Rhode Island | 12 of 29 | 41.4% |
| South Carolina | 27 of 89 | 30.3% |
| South Dakota | 9 of 30 | 30% |
| Tennessee | 31 of 156 | 19.9% |
| Texas | 161 of 407 | 39.6% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 16 of 53 | 30.2% |
| Vermont | 3 of 14 | 21.4% |
| Virginia | 55 of 144 | 38.2% |
| Washington | 50 of 114 | 43.9% |
| West Virginia | 21 of 69 | 30.4% |
| Wisconsin | 46 of 96 | 47.9% |
| Wyoming | 3 of 13 | 23.1% |
Medicare Part D paid for 259,827 30-day fills of Ingrezza in 2024 for about 32,161 enrollees, at an average total cost of $7,334.31 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Ingrezza and the rest of a client's list on every plan in their county.
Estimate Ingrezza costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.